The University of Notre Dame DU Lac was awarded a $622,340.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a performance period from June 1, 2025 to May 31, 2027, supports the development of multispecific bridge nanoparticles to engage T cells and off-the-shelf CAR-T cells against antigen-positive endothelial cell tumors, with the goal of enhancing antitumor immune activity. This research aims to transform...
This Project Grant award of $939,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports research conducted by the University of Notre Dame's Notre Dame Research Division, known as the Office of Research, focused on analyzing the relationship between host obesity and therapeutic response in ovarian cancer. The project aims to advance understanding and treatment of this disease, with an...
The federal Project Grant award of $200,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research conducted by Northwestern University to elucidate the neural basis of hallucinations in Parkinson's disease. The award, effective July 1, 2025 through June 30, 2027, will enable Northwestern University's researchers to investigate this critical medical challenge and develop innovative solutions to transform healthcare for military...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
This federal Project Grant award from the Office of Naval Research (ONR) under the Basic and Applied Scientific Research program (CFDA 12.300) provides $1,604,627.00 to the University of Notre Dame DU Lac to support masters and STEM programs in hypersonic systems research over a period of 3 years from March 1, 2025 to February 28, 2028. The funding supports fundamental and applied research at the University of Notre Dame to advance naval capabilities, enhance technological understanding, and...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The University of Notre Dame DU Lac was awarded a $150,000 Project Grant from the Air Force Research Laboratory (AFRL) under the Air Force Defense Research Sciences Program (CFDA 12.800). The award, effective August 1, 2025 through July 31, 2028, is for a research project titled "Understanding and Improving Multi-Domain Warfighter Immunity". The program supports fundamental and applied scientific research to maintain technological superiority for the U.S. Air Force and Space Force,...
This federal Project Grant award, with a total funding amount of $480,313, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award will support research conducted by Duke University, a leading private research institution, to investigate NUAK2 as a novel splicing regulatory kinase in neuroendocrine prostate cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by...
This federal Project Grant award for $1,399,812.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant is awarded to the Regents of the University of Minnesota to conduct research on outcomes and late effects in pediatric and adolescent germ cell tumor survivors. This funding will enable...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...